PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Methotrexate 25mg/5ml oral liquid
1001030U0AAAAAA
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 27.5mg/0.55ml inj pre-filled syringes
1001030U0AABNBN
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 3.75mg/5ml oral liquid
1001030U0AAAJAJ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 30mg/1.5ml inj pre-filled syringes
1001030U0AABRBR
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 4mg/5ml oral liquid
1001030U0AAAUAU
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 50mg/5ml oral liquid
1001030U0AAANAN
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 5mg/5ml oral liquid
1001030U0AAAFAF
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 6mg/5ml oral liquid
1001030U0AAAWAW
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 7.5mg/0.75ml inj pre-filled syringes
1001030U0AAAZAZ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 750micrograms/5ml oral liquid
1001030U0AAAQAQ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 7mg/5ml oral liquid
1001030U0AAAMAM
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 8mg/5ml oral liquid
1001030U0AAAPAP
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methyl salicylate 25% liniment
1003020N0AAAAAA
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Methyl salicylate 70mg/g topical solution
1003020N0AABBBB
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Methyl salicylate liquid
1003020N0AAAFAF
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Metoject 10mg/1ml solution for injection pre-filled syringes
1001030U0BEACBB
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 12.5mg/0.25ml inj pre-filled syringes
1001030U0BEALBK
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 15mg/1.5ml inj pre-filled syringes
1001030U0BEADBC
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 20mg/2ml solution for injection pre-filled syringes
1001030U0BEABBA
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 22.5mg/0.45ml inj pre-filled syringes
1001030U0BEANBM
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 25mg/2.5ml inj pre-filled syringes
1001030U0BEAEBD
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 27.5mg/0.55ml inj pre-filled syringes
1001030U0BEAPBN
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 30mg/0.6ml inj pre-filled syringes
1001030U0BEAKBJ
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 7.5mg/0.15ml inj pre-filled syringes
1001030U0BEAFBE
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 7.5mg/0.75ml inj pre-filled syringes
1001030U0BEAAAZ
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.